Editorial: Benign prostatic hyperplasia management - Statistical significance may not translate into clinical relevance

Journal of Urology

Volumn 171, Issue 3, 2004, Pages 1207-1208

  Kaplan, Steven A ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FINASTERIDE; MELATONIN; STEROID 5ALPHA REDUCTASE INHIBITOR;

CLINICAL MEDICINE; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; EDITORIAL; ERECTILE DYSFUNCTION; HEALTH CARE FINANCING; HOLMIUM LASER; HOLMIUM LASER ENUCLEATION PROSTATECTOMY; HUMAN; LIBIDO DISORDER; MALE; METHODOLOGY; NOCTURIA; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REIMBURSEMENT; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; TISSUE; TRANSURETHRAL ELECTROVAPORIZATION; TRANSURETHRAL RESECTION; NOTE; TREATMENT OUTCOME;

HUMANS; MALE; PROSTATIC HYPERPLASIA; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME;

EID: 1642407056     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000113724.04816.c0     Document Type: Editorial

References (4)

1. McConnell, J. D., Bruskewitz, R., Walsh, P., Andriole, G., Lieber, M., Holtgrewe, H. L. et al: The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med, 338: 557, 1998
2. McConnell, J. D., Roehrborn, C. G., Bautista, O. M., Andriole, G. L., Dixon, C. M., Kusek, J. W. et al: The long term effect of doxazosin, finasteride and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med, 349: 2385, 2003
3. Barry, M. J., Williford, W. O., Chang, Y. C., Machi, M., Jones, K. M., Walker-Corkey, E. et al: Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J Urol, 154: 1770, 1995
4. Holtgrewe, H. L.: Transurethral prostatectomy. Urol Clin North Am, 22: 357, 1995